Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 123

Similar articles for PubMed (Select 11990517)

1.

Physical performance, toxicity, and quality of life as assessed by the physician and the patient.

Luoma ML, Hakamies-Blomqvist L, Sjöström J, Mouridsen H, Pluzanska A, Malmström P, Bengtsson NO, Hultborn R, Ostenstaad B, Mjaaland I, Valvere V, Wist E, Baldursson G, Ahigren J, Blomqvist C.

Acta Oncol. 2002;41(1):44-9.

PMID:
11990517
2.

The prognostic effects of performance status and quality of life scores on progression-free survival and overall survival in advanced ovarian cancer.

Carey MS, Bacon M, Tu D, Butler L, Bezjak A, Stuart GC.

Gynecol Oncol. 2008 Jan;108(1):100-5. Epub 2007 Oct 24.

PMID:
17920108
3.

Assessment of long-term quality of life in patients with anal carcinomas treated by radiotherapy with or without chemotherapy.

Allal AS, Sprangers MA, Laurencet F, Reymond MA, Kurtz JM.

Br J Cancer. 1999 Jul;80(10):1588-94.

4.
5.

Timing of quality of life (QoL) assessments as a source of error in oncological trials.

Hakamies-Blomqvist L, Luoma ML, Sjöström J, Pluzanska A, Sjödin M, Mouridsen H, Østenstad B, Mjaaland I, Ottosson S, Bergh J, Malmström PO, Blomqvist C.

J Adv Nurs. 2001 Sep;35(5):709-16.

PMID:
11529973
6.

Deterioration of quality of life of high-risk breast cancer patients treated with high-dose chemotherapy: the PEGASE 01 Quality of Life Study.

Marino P, Roché H, Biron P, Janvier M, Spaeth D, Fabbro M, Linassier C, Delozier T, Martin AL, Santin G, Moatti JP; PEGASE Group.

Value Health. 2008 Jul-Aug;11(4):709-18. doi: 10.1111/j.1524-4733.2007.00306.x. Epub 2008 Jan 8.

PMID:
18194401
7.

Prospective assessment of quality of life of female cancer patients.

Greimel E, Thiel I, Peintinger F, Cegnar I, Pongratz E.

Gynecol Oncol. 2002 Apr;85(1):140-7.

PMID:
11925134
8.

The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30.

Guzelant A, Goksel T, Ozkok S, Tasbakan S, Aysan T, Bottomley A.

Eur J Cancer Care (Engl). 2004 May;13(2):135-44.

PMID:
15115469
9.

Influence of clinical parameters on quality of life during chemotherapy in patients with advanced non-small cell lung cancer: application of a general linear model.

Morita S, Kobayashi K, Eguchi K, Matsumoto T, Shibuya M, Yamaji Y, Sakamoto J, Ohashi Y.

Jpn J Clin Oncol. 2003 Sep;33(9):470-6.

10.

Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial.

Paccagnella A, Favaretto A, Oniga F, Barbieri F, Ceresoli G, Torri W, Villa E, Verusio C, Cetto GL, Santo A, De Pangher V, Artioli F, Cacciani GC, Parodi G, Soresi F, Ghi MG, Morabito A, Biason R, Giusto M, Mosconi P, Chiarion Sileni V; GSTVP (Gruppo di Studio Tumori Polmonari del Veneto).

Lung Cancer. 2004 Jan;43(1):83-91.

PMID:
14698542
11.

Randomized study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group comparing quality of life in patients with ovarian cancer treated with cisplatin/paclitaxel versus carboplatin/paclitaxel.

Greimel ER, Bjelic-Radisic V, Pfisterer J, Hilpert F, Daghofer F, du Bois A; Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group.

J Clin Oncol. 2006 Feb 1;24(4):579-86.

12.

Depression and functional impairment independently contribute to decreased quality of life in cancer patients prior to chemotherapy.

Wedding U, Koch A, Röhrig B, Pientka L, Sauer H, Höffken K, Maurer I.

Acta Oncol. 2008;47(1):56-62.

PMID:
18097778
13.

Impact of lapatinib monotherapy on QOL and pain symptoms in patients with HER2+ relapsed or refractory inflammatory breast cancer.

Kaufman B, Wu Y, Amonkar MM, Sherrill B, Bachelot T, Salazar V, Viens P, Johnston S.

Curr Med Res Opin. 2010 May;26(5):1065-73. doi: 10.1185/03007991003680323.

PMID:
20214527
14.

Quality of life in metastatic breast cancer patients under chemotherapy or supportive care: a single-institution comparative study.

Karamouzis MV, Ioannidis G, Rigatos G.

Eur J Cancer Care (Engl). 2007 Sep;16(5):433-8.

PMID:
17760930
15.

[Adjuvant chemotherapy with mitoxantrone, cyclophosphamide and 5-fluorouracil in breast neoplasms: therapeutic life].

Genre D, Macquart-Moulin G, Bouscary ML, Viens P, Cowen D, Packer y Comyn I, Moatti JP, Maraninchi D.

Bull Cancer. 1997 Mar;84(3):240-6. French.

PMID:
9207868
16.

Quality of life analyses in a clinical trial of DPPE (tesmilifene) plus doxorubicin versus doxorubicin in patients with advanced or metastatic breast cancer: NCIC CTG Trial MA.19.

Liu J, Tu D, Dancey J, Reyno L, Pritchard KI, Pater J, Seymour LK.

Breast Cancer Res Treat. 2006 Dec;100(3):263-71. Epub 2006 Jul 6.

PMID:
16823511
17.

Evaluating quality of life and pulmonary function of long-term survivors of non-small cell lung cancer treated with radical or postoperative radiotherapy.

Ozturk A, Sarihan S, Ercan I, Karadag M.

Am J Clin Oncol. 2009 Feb;32(1):65-72. doi: 10.1097/COC.0b013e31817e6ec2.

PMID:
19194128
18.

Evaluation of EORTC QLQ-C30 questionnaire in patients undergoing in-hospital chemotherapy for gastrointestinal cancer in Japan.

Kato J, Nagahara A, Iijima K, Yoshimura M, Osada T, Yoshizawa T, Watanabe S.

J Gastroenterol Hepatol. 2008 Dec;23 Suppl 2:S268-72. doi: 10.1111/j.1440-1746.2008.05414.x.

PMID:
19120910
20.

Effects of socioeconomic factors and cancer survivors' worries on their quality of life (QOL) in Japan.

Kobayashi K, Morita S, Shimonagayoshi M, Kobayashi M, Fujiki Y, Uchida Y, Yamaguchi K.

Psychooncology. 2008 Jun;17(6):606-11.

PMID:
17972358
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk